Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.
about
Androgen receptor signaling in hepatocellular carcinoma and pancreatic cancersPhase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma.Transarterial chemoembolization with cisplatin as second-line treatment for hepatocellular carcinoma unresponsive to chemoembolization with epirubicin-Lipiodol emulsion.Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II cliPhase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-FluorouracilA Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma.Transarterial infusion chemotherapy with cisplatin plus S-1 for hepatocellular carcinoma treatment: a phase I trial.Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.Future perspectives on the treatment of hepatocellular carcinoma with cisplatin.Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma.Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative studyA safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma.Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial.Newer treatments for advanced hepatocellular carcinoma.Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age.Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).Current status of hepatocellular carcinoma treatment in Japan: hepatic arterial infusion chemotherapy.Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan.Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.Chemotherapy for hepatocellular carcinoma: The present and the future.The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.Current chemotherapies for advanced hepatocellular carcinoma.Effect of double platinum agents, combination of miriplatin-transarterial oily chemoembolization and cisplatin-hepatic arterial infusion chemotherapy, in patients with hepatocellular carcinoma: Report of two casesAntitumoral effect of Ocoxin in hepatocellular carcinoma.Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.Comparison of the antitumor efficacy of transcatheter arterial chemoembolization with a miriplatin-iodized oil suspension and a cisplatin-iodized oil suspension for hepatocellular carcinoma.A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.Chemotherapy for hepatocellular carcinoma: current status and future perspectives.Local control and prognostic significance of transarterial treatment for limited recurrence of ovarian cancer as third-line and beyond therapy.Pharmacokinetics and Histopathological Findings of Chemoembolization Using Cisplatin Powder Mixed with Degradable Starch Microspheres in a Rabbit Liver Tumor Model.Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: a propensity score-based weighting.Comparison of the anti-tumor effects of two platinum agents (miriplatin and fine-powder cisplatin).Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.Efficacy of hepatic arterial infusion chemotherapy in combination with irradiation for advanced hepatocellular carcinoma with portal vein invasion.A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapyEfficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
P2860
Q27004276-A4ED5E36-9993-476C-BFC3-979257AA5B84Q31096586-3D39944C-CAEE-484E-A5B5-1E829FCA4383Q33393492-14C0DAC4-B00B-41DF-8301-F7EE469AA92DQ33418923-BE45250E-7B5C-4DA6-A762-ED194DAA7A40Q33428936-D63BEA05-ABEF-4E0F-8ADA-400E2CC9A8BEQ33440349-D48F4C3A-AEF2-4515-8E16-A96FF430D923Q33573019-4B833AA9-D324-4675-8899-F3D3E19ED049Q33660203-728EE4D0-6F56-4877-8283-30D15A5297A1Q34390215-342B0C49-7BAB-49E6-81B7-A0427677115EQ35051975-5CCFBEE5-B1A7-47FE-BEDB-A16DFD4E608BQ36120874-BA39C743-1C91-4157-9C54-A57DAE09B893Q36230740-152D88F7-B6BF-4CB7-89D3-5D00E88C5D27Q37232002-8B1DD1CC-5AEE-4178-9173-60960A66F967Q37387978-9A2FCFDD-9406-483B-834F-EC37625B80DAQ37642185-E3048EDC-2B91-430A-BAED-9AB80D9EA2AEQ37708002-2DA565A1-0126-4E65-8D7C-639BAD8E4791Q38022245-CA8193E5-2378-4988-8496-70A5D458C1E2Q38032906-7C40E995-3040-4AE2-B160-0185BD19A22FQ38161384-27355189-D844-42AA-A56C-F853D661FFB9Q38410821-92A94A05-D5D2-4D55-A6B6-8DBB466CB9C1Q38639762-708F7FC4-6651-4B43-B190-80D45B655AF3Q39709255-02DAC4F4-243F-4A24-B24F-73DC9BC1E380Q39863380-3FC335DD-CBBE-4B54-A07A-DE29DCFE4C84Q40729549-11560107-B068-4C75-8341-A9C93F85CAC5Q41072005-1A0FF750-C2BF-4632-978B-A8A6E8A69E88Q41145089-652A5AF9-B2B5-4787-974E-997FCC22EF8CQ44769237-2289602D-16B3-435F-A3B9-D6F2622360D7Q46322363-7B24504D-5C6B-44C3-98FD-F12A859655CAQ46355180-5DDED274-026E-45F9-A1E6-EA4444E33D01Q46821188-7CEF05C6-7AFF-4D8C-89BA-BC77F5AC8FBFQ47775953-63751CBB-A8F1-4CED-86E1-9B5FE362156EQ48088986-23A9F7F1-ACA0-4CC4-AC79-5F5EE3A8111AQ51095274-477C957B-BEB9-4F0C-BB81-A1501AB256D9Q53161133-50B57862-706D-42C9-AC22-0A3E8521A454Q53247409-85E66BE1-F021-4807-9260-4D8ED8498D92Q53279945-246E501A-C255-4839-ABB4-9685D64114A7Q53573051-3F3D458A-128A-4753-9846-A5225DDDF787Q53615583-F4EAFD0C-C206-4FA8-A098-B0CEE51AFE92Q57491231-2E6C9B30-A80E-4997-A86E-144A71AAE12DQ58806056-C8FD7404-F499-4F65-BEC4-779F508756B0
P2860
Phase II study of hepatic arterial infusion of a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@ast
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@en
type
label
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@ast
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@en
prefLabel
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@ast
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
Phase II study of hepatic arte ...... nced hepatocellular carcinoma.
@en
P2093
Hiraku Yodono
Hironobu Nakamura
Masaharu Yoshikawa
Naofumi Ono
Takafumi Ichida
P2860
P304
P356
10.1111/J.1872-034X.2008.00338.X
P577
2008-05-01T00:00:00Z